ISPOR Releases 2022 Annual Report

Published Apr 25, 2023

ANNOUNCEMENT

Return to In-Person Events Is Highlighted in New Report

LMIC Report CoverLawrenceville, NJ, USA—May 25, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its 2022 annual report has been published. This year’s report highlights how the Society has successfully moved through and beyond the pandemic and returned to in-person events as it advances its mission to improve healthcare decisions. During 2022 the Society:

  • Returned to in-person events with its 2 highly successful annual conferences—ISPOR 2022 and ISPOR Europe 2022
  • Organized and held a Asia Pacific Summit, Payer Summit, 5 Health Technology Assessment Roundtables, 3 Patient Engagement Roundtables, 51 short courses, and 39 webinars
  • Published 10 new ISPOR Reports in Value in Health, 4 of which were Good Practices Reports)
    • This included the update of the Society’s most downloaded report, “Consolidated Health Economic Evaluation Reporting Standards 2022,” also known as “CHEERS 2022
  • Grew membership to 19,000 individual and chapter members representing 111 countries across the globe
  • Released a number of new content offerings, including the ISPOR 2022-2023 Top 10 HEOR Trends Report, About Real-World Evidence website content, and the HEOR News Desk microsite
  • Responded to 13 calls for comment that included responses to the US Food and Drug Administration (FDA), EUnetHTA, National Institute for Health and Care Excellence (NICE), and the European Medicines Agency (EMA)
  • Announced plans for ISPOR’s CEO and Executive Director for the past 8 years, Nancy S. Berg, to retire

The full report can be downloaded here.

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×